分子动力学模拟揭示了MGL-3196对甲状腺素受体β抗性的机制
Yi Lu1,2, Chun Chen1, Deyi Zhuang1
1Fujian Key Laboratory of Neonatal Diseases, Xiamen Key Laboratory of Neonatal Diseases, Xiamen Childreǹs Hospital (Children's Hospital of Fudan University at Xiamen), Xiamen 361006, China.
ACS omega
|May 20, 2024
概括
MGL-3196,一种用于非酒精性脂肪肝炎 (NASH) 的新药,在具有特定甲状腺素受体β (TRβ) 突变的患者中可能无效. 这些突变,R243Q和H435R,使TRβ对MGL-3196不敏感,影响治疗疗效.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲状腺素受体β (TRβ) 是一个核受体,对脂质代谢至关重要.
- 非酒精性脂肪肝炎 (NASH) 是一种肝脏疾病,治疗选择有限,使TRβ成为关键的治疗点.
- MGL-3196 (Resmetirom) 是一个有前途的TRβ激动剂,在NASH临床试验中取得了成功.
研究的目的:
- 研究MGL-3196与TRβ.的相互作用的分子机制.
- 在NASH患者中确定对MGL-3196治疗的潜在耐药性机制.
主要方法:
- 用全原子分子动态模拟来研究MGL-3196和TRβ相互作用.
- 对比了MGL-3196在流行TRβ突变中的结合模式.
主要成果:
- 确定了R243Q和H435RTRβ突变是导致MGL-3196不敏感的原因.
- 这些突变位于TRβ.的结合体结合口袋附近或内部.
- 在NASH中,TRβ突变可能导致对MGL-3196治疗的抗性.
结论:
- TRβ突变,特别是R243Q和H435R,可以赋予MGL-3196.6的耐药性.
- 这些发现强调了考虑TRβ突变对于个性化NASH治疗策略的重要性.
- 了解这些相互作用对于推进超越NASH的TRβ向治疗至关重要.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
4.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K


